cardiovascular disease

(redirected from Cardiovascular disorders)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to Cardiovascular disorders: Cardiovascular diseases, Cardiac disease

cardiovascular disease

any abnormal condition characterized by dysfunction of the heart and blood vessels. In the United States, cardiovascular disease is the leading cause of death. Some common kinds of cardiovascular disease are atherosclerosis, myocardiopathy, rheumatic heart disease, syphilitic endocarditis, and systemic venous hypertension.

cardiovascular disease

Cardiovascular disorder Internal medicine Any of the diseases–ASHD, CAD, cerebrovascular disease, HTN–that primarily impact the heart and blood vessels

cardiovascular disease

Any disease of the heart or the blood vessels. Cardiovascular disease is by far the commonest cause of death and disability in the Western World. See also ATHEROSCLEROSIS.

Cardiovascular disease

Disease that affects the heart and blood vessels.
Mentioned in: Lipoproteins Test
References in periodicals archive ?
OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, announced today that Nicholas Landekic, President and Chief Executive Officer, will present an overview and update on the company at the J.
a cardiovascular surgery device manufacturer, focuses on the development and introduction of products designed to improve patient outcomes through the early treatment of cardiovascular disorders and disease, specifically products used by cardiac surgeons to ablate cardiac tissue as a potential means to treat atrial fibrillation.
Due to the cardiovascular side effects associated with beta-agonists, caution is generally recommended for patients with cardiovascular disorders (especially coronary insufficiency, cardiac arrhythmias and hypertension), diabetes, hyperthyroidism, or convulsive disorders.
Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that an abstract describing the effects of darusentan on resistant hypertension has been selected for oral presentation at the American Heart Association Scientific Sessions conference to be held Nov.

Full browser ?